Evidence map›Paper›PMID 42668479›Full record

ArticleForensic science international. Synergy2026

HelixCross - Design and development of an AI-powered cross-examination simulation for forensic expert testimony training.

Mark Barash, Bruce Budowle

Abstract read
In one paragraph

Article in Forensic science international. Synergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark BarashDepartment of Justice Studies, San Jose State University, San Jose, CA, 95192, USA.
Bruce BudowleDepartment of Forensic Medicine, University of Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Forensic testimony is where science meets the courtroom, and it is one of the critical forensic skills taught largely by apprenticeship. An examiner who overstates a match, mishandles a probability, or cannot support a method under direct or cross-examination can weaken the evidence in precisely the cases that rely on it. Yet in most forensic laboratories, testimony preparation remains largely informal, mentor-dependent, and unscalable. Consequently, many practitioners first face rigorous cross-examination at trial. To address this gap, HelixCross, an alpha-stage, publicly accessible, prompt-engineered large language model (LLM) agent, was developed. It uses retrieval-augmented generation (RAG) to simulate defense counsel cross-examination and provide structured coaching on demand. Deployed on two LLM platforms to widen access, it pairs a phase-based curriculum with a synthetic DNA case, a scripted cross-plan with embedded fallacy traps, and a ten-dimension coaching rubric. The initial curriculum targets recurrent problems in DNA testimony, including likelihood-ratio interpretation, proposition discipline, activity-level overreach, probabilistic-genotyping assumptions, and unwarranted certainty. This paper describes the architecture, training assets, and governance considerations. Evaluation to date consists of informal functional testing by the developers and a few early-stage users, without predefined acceptance criteria, independent ratings, or learner outcome data. Testing also exposed platform-dependency risks, including session-state failure after a vendor-side model update. HelixCross is therefore presented as a transparent development-stage tool and curriculum package intended to enhance the resilience, clarity, accuracy, and scientific integrity of forensic expert testimony - a contribution that a follow up phase of controlled evaluation is required to demonstrate.

Indexed as

Expert testimonyForensic scienceLarge language modelProbabilistic genotypingSimulation-based education

Identifiers

PMID42668479
PMCPMC13524633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.